DNMT inhibition has been shown to induce upregulation of MHC Class I in other cancer types.50 Together, these data demonstrate that pharmacologic modulation of DNA methylation in DIPG can have a profound impact on gene expression and immunogenicity of DIPG. This evidence concerns the gene DNMT1 and cancer.